PENWEST PHARMACEUTICALS CO
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: PENWEST PHARMACEUTICALS CO, 10-Q, 2000-11-14
Next: GETTY IMAGES INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED BALANCE SHEET AT SEPTEMBER 30, 2000 AND THE CONDENSED
STATEMENT OF OPERATIONS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           6,627
<SECURITIES>                                         0
<RECEIVABLES>                                    7,593
<ALLOWANCES>                                       263
<INVENTORY>                                      6,812
<CURRENT-ASSETS>                                21,735
<PP&E>                                          34,870
<DEPRECIATION>                                  17,000
<TOTAL-ASSETS>                                  44,871
<CURRENT-LIABILITIES>                            8,060
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            13
<OTHER-SE>                                      33,891
<TOTAL-LIABILITY-AND-EQUITY>                    44,871
<SALES>                                         10,090
<TOTAL-REVENUES>                                11,242
<CGS>                                            7,050
<TOTAL-COSTS>                                    7,050
<OTHER-EXPENSES>                                 3,464
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  15
<INCOME-PRETAX>                                (2,032)
<INCOME-TAX>                                        65
<INCOME-CONTINUING>                            (2,097)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,097)
<EPS-BASIC>                                     (0.17)
<EPS-DILUTED>                                   (0.17)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission